ATC code M05
ATC code M05 Drugs for treatment of bone diseases is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup M05 is part of the anatomical group M Musculo-skeletal system.[4]
| ATC code M: Musculo-skeletal system |
|---|
|
| Other ATC codes |
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM05.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
M05B Drugs affecting bone structure and mineralization
M05BA Bisphosphonates
- M05BA01 Etidronic acid
- M05BA02 Clodronic acid
- M05BA03 Pamidronic acid
- M05BA04 Alendronic acid
- M05BA05 Tiludronic acid
- M05BA06 Ibandronic acid
- M05BA07 Risedronic acid
- M05BA08 Zoledronic acid
M05BB Bisphosphonates, combinations
- M05BB01 Etidronic acid and calcium, sequential
- M05BB02 Risedronic acid and calcium, sequential
- M05BB03 Alendronic acid and colecalciferol
- M05BB04 Risedronic acid, calcium and colecalciferol, sequential
- M05BB05 Alendronic acid, calcium and colecalciferol, sequential
- M05BB06 Alendronic acid and alfacalcidol, sequential
- M05BB07 Risedronic acid and colecalciferol
- M05BB08 Zoledronic acid, calcium and colecalciferol, sequential
- M05BB09 Ibandronic acid and colecalciferol
M05BC Bone morphogenetic proteins
- M05BC01 Dibotermin alfa
- M05BC02 Eptotermin alfa
M05BX Other drugs affecting bone structure and mineralization
- M05BX01 Ipriflavone
- M05BX02 Aluminium chlorohydrate
- M05BX03 Strontium ranelate
- M05BX04 Denosumab
- M05BX05 Burosumab
- M05BX06 Romosozumab
- M05BX07 Vosoritide
- M05BX08 Menatetrenone
- M05BX53 Strontium ranelate and colecalciferol
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code M05". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QM05". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.